Literature DB >> 16103287

Hemodynamically "stable" patients with peritonitis after penetrating abdominal trauma: identifying those who are bleeding.

Carlos V R Brown1, George C Velmahos, Angela L Neville, Peter Rhee, Ali Salim, Burapat Sangthong, Demetrios Demetriades.   

Abstract

HYPOTHESIS: Despite initial presentation, hemodynamically stable patients with penetrating abdominal trauma may have significant ongoing hemorrhage and major intra-abdominal injuries requiring emergent surgical intervention.
DESIGN: Cohort analytic study.
SETTING: Academic, level I trauma center. PATIENTS: One hundred thirty-nine consecutive hemodynamically stable patients with penetrating abdominal trauma in whom peritonitis was the sole indication for laparotomy. MAIN OUTCOME MEASURES: The primary outcome was the amount of blood initially found at laparotomy. Secondary outcomes included additional intraoperative blood loss, intraoperative hypotension, transfusion, fluid, and vasopressor requirement; need for admission to the intensive care unit and mechanical ventilation; complications; survivor length of stay in the hospital and intensive care unit; and mortality.
RESULTS: The admission systolic blood pressure (mean +/- SD, 131 +/- 22 mm Hg) and heart rate (mean +/- SD, 91 +/- 22 beats/min) were normal. Median time from peritonitis to incision was 40 minutes. Ninety-seven percent of patients had intra-abdominal injury, including 81%, hollow visceral; 36%, solid organ; and 11%, vascular injury. Though most patients had less than 750 mL(3) of blood found initially at laparotomy, there were 11% with 750 to 1500 mL(3) and 7% with 1500 mL(3) or more. Intraoperative hypotension (25%) and blood transfusion (39%) were common. Postoperatively, 40% of patients required intensive care (78% of them requiring mechanical ventilation) and 19% required additional transfusion within 24 hours. Complications occurred in 25% of patients, with intra-abdominal abscess (12%) and wound infection (7%) being the most common. Three patients died, 2 of exsanguination and 1 of multisystem organ failure.
CONCLUSIONS: Following penetrating abdominal trauma, peritonitis should be a trigger for emergent operation regardless of vital signs, because hemodynamic "stability" does not reliably exclude significant hemorrhage. Vascular injury, subsequent hypotension, blood transfusion, and complicated postoperative course are common in this population.

Entities:  

Mesh:

Year:  2005        PMID: 16103287     DOI: 10.1001/archsurg.140.8.767

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  6 in total

1.  The efficacy of novel anatomical sites for the assessment of muscle oxygenation during central hypovolemia.

Authors:  Justin D Sprick; Babs R Soller; Caroline A Rickards
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-19

Review 2.  [Approach to liver, spleen and pancreatic injuries including damage control surgery of terrorist attacks].

Authors:  G A Stavrou; M J Lipp; K J Oldhafer
Journal:  Chirurg       Date:  2017-10       Impact factor: 0.955

3.  Conservative versus operative management in stable patients with penetrating abdominal trauma: the experience of a Canadian level 1 trauma centre.

Authors:  Sean Bennett; Aysah Amath; Heather Knight; Jacinthe Lampron
Journal:  Can J Surg       Date:  2016-09       Impact factor: 2.089

4.  Inferior vena caval injury following self-inflicted abdominal stab wound.

Authors:  Abdul H M Quraishi
Journal:  Indian J Surg       Date:  2008-03-19       Impact factor: 0.656

5.  Leukocytosis as prognostic indicator of major injury.

Authors:  Lorenzo Paladino; Ramanand A Subramanian; Elisabeth Bonilla; Richard H Sinert
Journal:  West J Emerg Med       Date:  2010-12

6.  Effects of Occult Hypoperfusion on Local Circulation and Inflammation - An Analysis in a Standardized Polytrauma Model.

Authors:  Sascha Halvachizadeh; Yannik Kalbas; Michel Paul Johan Teuben; Henrik Teuber; Nikola Cesarovic; Miriam Weisskopf; Paolo Cinelli; Hans-Christoph Pape; Roman Pfeifer
Journal:  Front Immunol       Date:  2022-06-21       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.